Efficacy of the NVX-CoV2373 COVID-19 Vaccine Co-Administered With Seasonal Flu Vaccines
Researchers conducted a study to assess the efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with a seasonal influenza vaccine.
Influenza
Prevnar 20 Coadministered With Flu Vaccine Immunogenic, Safe in Older Adults
The randomized, double-blind trial enrolled a total of 1796 participants, of which 1727 completed the study.
Flu Vaccine May Protect Against Adverse Events After SARS-CoV-2
Individuals with flu vaccination have lower risks for sepsis, stroke, and DVT, emergency department and ICU admissions.
Considerable Burden of Noninfluenza Respiratory Virus Infection
Study authors analyzed patient data to assess the burden of noninfluenza respiratory virus infection vs influenza in previous seasons.
Approximately 1 in 3 Patients With ASCVD Not Receiving Flu Shot
About one in three individuals with ASCVD did not receive an influenza vaccination in the past year.
Cost-Effectiveness of Increased Influenza Vaccination to Reduce MACE Readmission Risk
Achieving an influenza vaccination rate of at least 80% could be cost-saving.
Experimental ‘Universal’ Influenza Vaccine Being Evaluated in Healthy Volunteers
The National Institutes of Health (NIH) has announced the initiation of a phase 1 clinical trial assessing the safety, tolerability, and efficacy of a “universal” influenza vaccine candidate, H1ssF_3928, in healthy adult patients.
CDC: Flu Season May Have Peaked in the United States
Milder strain of flu has been most common cause of cases this flu season
2017-2018 Influenza Vaccine Prevents Substantial Burden
The current available influenza vaccine may have prevented substantial cases of influenza-associated adverse outcomes.
Influenza-Like Illness Associated With Increased Risk for Stroke, Cervical Artery Dissection
Influenza-like illness is associated with an increased risk for ischemic stroke and cervical artery dissection.
- Loading...
Loading...
Next post in Stroke
Loading... 
Loading...